The tissue renin-angiotensin system in human pancreas

被引:132
作者
Tahmasebi, M
Puddefoot, JR
Inwang, ER
Vinson, GP
机构
[1] Queen Mary Univ London, Dept Biochem, Div Biomed Sci, London E1 4NS, England
[2] Royal Hosp Trust, Breast Unit, London E1 1BB, England
关键词
D O I
10.1677/joe.0.1610317
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Evidence exists for the presence of a discrete tissue renin-angiotensin system (RAS) in mouse and rat pancreas that is thought largely to be associated with the vasculature. To investigate this in the human pancreas, and to establish whether the cellular sites of RAS components include the islets of Langerhans, we used immunocytochemistry to localise the expression of angiotensin II (AT1) receptors and (pro)renin, and non-isotopic in situ hybridisation to localise transcription of the (pro)renin gene. Identification of cell types in the islets of Langerhans was achieved using antibodies to glucagon and insulin. The results show the presence of the AT1 receptor and (pro)renin both in the beta cells of the islets of Langerhans, and in endothelial cells of the pancreatic vasculature. Transcription of (pro)renin mRNA, however, was confined to connective tissue surrounding the blood vessels and in reticular fibres within the islets. These findings are similar to those obtained in other tissues, and suggest that renin may be released from its sites of synthesis and taken up by possible cellular sites of action. The results presented here suggest that a tissue RAS may be present in human pancreas and that it may directly affect beta cell function as well as pancreatic blood flow.
引用
收藏
页码:317 / 322
页数:6
相关论文
共 50 条
[11]   EVIDENCE FOR AN INTRINSIC ANGIOTENSIN SYSTEM IN THE CANINE PANCREAS [J].
CHAPPELL, MC ;
MILLSTED, A ;
DIZ, DI ;
BROSNIHAN, KB ;
FERRARIO, CM .
JOURNAL OF HYPERTENSION, 1991, 9 (08) :751-759
[12]   PHARMACOLOGICAL CHARACTERIZATION OF ANGIOTENSIN-II BINDING-SITES IN THE CANINE PANCREAS [J].
CHAPPELL, MC ;
DIZ, DI ;
JACOBSEN, DW .
PEPTIDES, 1992, 13 (02) :313-318
[13]   Effect of lisinopril on progression of retinopathy in normotensive people with type 1 diabetes [J].
Chaturvedi, N ;
Sjolie, AK ;
Stephenson, JM ;
Abrahamian, H ;
Keipes, M ;
Castellarin, A ;
Rogulja-Pepeonik, Z ;
Fuller, JH .
LANCET, 1998, 351 (9095) :28-31
[14]   REDUCED PROXIMAL TUBULE ANGIOTENSIN-II RECEPTOR EXPRESSION IN STREPTOZOTOCIN-INDUCED DIABETES-MELLITUS [J].
CHENG, HF ;
BURNS, KD ;
HARRIS, RC .
KIDNEY INTERNATIONAL, 1994, 46 (06) :1603-1610
[15]   Altered action of angiotensin II in patients with type 2 diabetes mellitus of recent onset [J].
Fliser, D ;
Keller, C ;
Bahrmann, P ;
Franek, E ;
Schreckling, H ;
Bergis, K ;
Ritz, E .
JOURNAL OF HYPERTENSION, 1997, 15 (03) :293-299
[16]   Lisinopril - A review of its pharmacology and use in the management of the complications of diabetes mellitus [J].
Goa, KL ;
Haria, M ;
Wilde, MI .
DRUGS, 1997, 53 (06) :1081-1105
[17]  
HARRISONBERNARD LM, 1997, AM J PHYSIOL, V42, pR170
[18]   Transcription of (pro)renin mRNA in the rat adrenal cortex, and the effects of ACTH treatment and a low sodium diet [J].
Ho, MM ;
Vinson, GP .
JOURNAL OF ENDOCRINOLOGY, 1998, 157 (02) :217-223
[19]   SYSTEMIC HYPERTENSION AND THE RENIN-ANGIOTENSIN SYSTEM IN DIABETIC VASCULAR COMPLICATIONS [J].
HSUEH, WA ;
ANDERSON, PW .
AMERICAN JOURNAL OF CARDIOLOGY, 1993, 72 (20) :H14-H21
[20]   Angiotensin II type 1 receptor expression in human breast tissues [J].
Inwang, ER ;
Puddefoot, JR ;
Brown, CL ;
Goode, AW ;
Marsigliante, S ;
Ho, MM ;
Payne, JG ;
Vinson, GP .
BRITISH JOURNAL OF CANCER, 1997, 75 (09) :1279-1283